ti-drug-category-vs
type: ValueSet
node role: treeRoot
id:
  v: ti-drug-category-vs
url:
  v: https://gematik.de/fhir/terminology/ValueSet/ti-drug-category-vs
  l: ti-drug-category-vs
version:
  v: 1.0.7
name:
  v: TIDrugCategoryVS
title:
  v: TI Drug Category ValueSet
status:
  v: active
experimental:
  v: false
date:
  v: 2025-09-12
publisher:
  v: gematik GmbH
contact:
  telecom:
    system:
      v: url
    value:
      v: https://www.gematik.de
description:
  v: The ValueSet for drug category.
jurisdiction:
  coding:
    system:
      v: urn:iso:std:iso:3166
      l: 3166
    code:
      v: DE
immutable:
  v: false
copyright:
  v: gematik GmbH
compose:
  include:
    system:
      v: https://gematik.de/fhir/epa-medication/CodeSystem/epa-drug-category-cs
      l: epa-drug-category-cs
expansion:
  timestamp:
    v: 2025-11-03
  contains:
    system:
      v: https://gematik.de/fhir/epa-medication/CodeSystem/epa-drug-category-cs
      l: epa-drug-category-cs
    code:
      v: 00
    display:
      v: Arzneimittel oder in die Arzneimittelversorgung nach § 31 SGB V einbezogenes Produkt
  contains:
    system:
      v: https://gematik.de/fhir/epa-medication/CodeSystem/epa-drug-category-cs
      l: epa-drug-category-cs
    code:
      v: 01
    display:
      v: BtM
  contains:
    system:
      v: https://gematik.de/fhir/epa-medication/CodeSystem/epa-drug-category-cs
      l: epa-drug-category-cs
    code:
      v: 02
    display:
      v: AMVV § 3a Abs. 1 (Thalidomid o. ä.)
  contains:
    system:
      v: https://gematik.de/fhir/epa-medication/CodeSystem/epa-drug-category-cs
      l: epa-drug-category-cs
    code:
      v: 03
    display:
      v: Sonstiges